<DOC>
	<DOCNO>NCT01428661</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy 8-week double-masked treatment tasimelteon placebo male female subject Major Depressive Disorder .</brief_summary>
	<brief_title>Melatonin Agonist Effects Tasimelteon Versus Placebo Patients With Major Depressive Disorder</brief_title>
	<detailed_description>This randomize , parallel , double-masked , placebo-controlled , multicenter outpatient study compare tasimelteon placebo treatment subject Major Depressive Disorder ( MDD ) . The study three phase : pre-randomization phase , randomization phase , open-label extension phase . The pre-randomization phase comprise screen visit subject 's initial eligibility evaluate . The randomization phase comprise 8-week double-masked segment . Subjects meet entry criterion study enter randomization phase . During phase , subject ask take either 20 mg tasimelteon placebo 8 week double-masked fashion . At end 8-week double-masked phase , subject complete 8-week treatment phase offer enroll 52-week open-label extension subject receive daily dose 20 mg tasimelteon .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Subjects diagnosis MDD , single recurrent episode , accord DSMIV TR criterion ; Current episode ≥4 week ≤1 year ; CGISeverity score ≥4 screen baseline . Lifetime history bipolar disorder ( I II ) , schizophrenia , schizoaffective disorder , eat disorder , obsessivecompulsive disorder ; Any current Axis I ( except general anxiety disorder long consider primary disorder ) Axis II disorder ; A positive test drug abuse screen visit and/or history drug alcohol abuse/dependence define DSMIV TR , Diagnostic Criteria Drug Alcohol Abuse Dependence , within past 12 month ; Formal psychotherapy within 3 month screen visit . General supportive psychotherapy acceptable ; Participation previous tasimelteon trial . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>tasimelteon</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>MDD</keyword>
	<keyword>depression</keyword>
</DOC>